焦磷酸钙沉积病全基因组关联研究揭示ENPP1为候选治疗靶点
本研究利用退伍军人事务部百万退伍军人计划中非洲裔和欧洲裔人群的公开全基因组关联研究汇总数据,对软骨钙质沉着症(3004例)和晶体性关节病(3766例)进行分析。在6号染色体上发现ENPP1和RNF144B两个全基因组显著位点,共定位分析支持其为候选因果基因。ENPP1编码的NPP1蛋白参与焦磷酸钙晶体形成,选择性NPP1抑制剂或可试用于焦磷酸钙沉积病的治疗。
要点
- 在非洲裔和欧洲裔人群中均发现软骨钙质沉着症的2个全基因组显著位点,位于6号染色体ENPP1和RNF144B基因内。
- 晶体性关节病队列分析支持上述发现,共定位分析进一步支持ENPP1和RNF144B为候选因果基因。
- ENPP1增加软骨钙质沉着症风险的等位基因与ENPP1表达升高相关。
核心结论
- ENPP1编码的NPP1蛋白产生腺苷单磷酸和无机焦磷酸,与钙离子共同导致焦磷酸钙晶体形成;选择性NPP1抑制剂或可作为焦磷酸钙沉积病的治疗进行试验。
研究设计与样本
- 利用退伍军人事务部百万退伍军人计划中非洲裔和欧洲裔人群的公开全基因组关联研究汇总数据,对Phecode定义的软骨钙质沉着症和晶体性关节病进行分析。
- 软骨钙质沉着症病例共3004例(非洲裔536例,欧洲裔2468例),晶体性关节病病例共3766例(非洲裔700例,欧洲裔3066例)。
- 主要分析为软骨钙质沉着症,次要分析为晶体性关节病,并检验软骨钙质沉着症遗传关联信号与基因表达遗传调控的共定位。
主要发现
- 在非洲裔和欧洲裔病例中均发现软骨钙质沉着症的2个全基因组显著位点,均位于6号染色体,信号分别位于ENPP1和RNF144B基因内。
- 晶体性关节病队列分析支持上述发现。
- 软骨钙质沉着症遗传关联信号与基因表达及可变剪接的遗传调控共定位分析进一步支持ENPP1和RNF144B为候选因果基因。
- 在ENPP1基因处,增加软骨钙质沉着症风险的等位基因与ENPP1表达升高相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The genetic basis of calcium pyrophosphate deposition (CPPD) disease is unknown. This limits the development of therapeutic strategies. We aimed to analyse a genome-wide association study (GWAS) on a large administrative database to identify new candidate causal genes for CPPD disease. METHODS: We used publicly available GWAS summary statistics for Phecode-defined chondrocalcinosis and crystal arthropathy from the Veterans Affairs Million Veteran Program in people of African (AFR) and European (EUR) ancestry. Included were 3004 (536 AFR and 2468 EUR) cases for chondrocalcinosis and 3766 (700 AFR and 3066 EUR) cases for crystal arthropathy (operationally interpreted as calcium crystal arthropathy). Our primary analysis was in chondrocalcinosis, with secondary analysis in crystal arthropathy. We tested for colocalisation of chondrocalcinosis genetic association signals with genetic control of gene expression. RESULTS: There were 2 genome-wide significant loci for chondrocalcinosis in both AFR and EUR cases, both on chromosome 6 (signals within the ENPP1 and RNF144B genes). Findings were supported by analysis of the crystal arthropathy cohort. Colocalisation analysis of chondrocalcinosis genetic association signals with genetic control of gene expression and alternative splicing further supported ENPP1 and RNF144B as candidate casual genes. At ENPP1, the allele that increases the risk for chondrocalcinosis was associated with increased ENPP1 expression. CONCLUSIONS: ENPP1 encodes ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (NPP1) that produces adenosine monophosphate (AMP) and inorganic pyrophosphate which, together with calcium ions, leads to the formation of calcium pyrophosphate crystals. Selective NPP1 inhibitors developed for infectious disease and cancer could be tested as treatment for CPPD disease.
引用
- Takei R, Rosenthal A, Pascart T, et al. Genome-wide association study in chondrocalcinosis reveals ENPP1 as a candidate therapeutic target in calcium pyrophosphate deposition disease. Ann Rheum Dis. 2025. PMID: 40483170. doi:10.1016/j.ard.2025.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。